Suppr超能文献

钾离子通道抑制剂4-氨基吡啶与γ-胱硫醚裂解酶抑制剂β-氰基丙氨酸或肾上腺素联合治疗可恢复血压,并提高Wistar大鼠过敏性休克模型的存活率。

Combined Treatment with KV Channel Inhibitor 4-Aminopyridine and either γ-Cystathionine Lyase Inhibitor β-Cyanoalanine or Epinephrine Restores Blood Pressure, and Improves Survival in the Wistar Rat Model of Anaphylactic Shock.

作者信息

Bellou Abdelouahab, Sennoun Nacira, Aburawi Elhadi H, Jayaraj Richard L, Alper Seth L, Alfaki Ibrahim Abdallah, Yasin Javed, Sekar Subramanian, Shafiuallah Mohamed, Al-Salam Suhail, Nemmar Abderrahim, Kazzam Elsadig, Mertes Paul Michel, Al-Hammadi Suleiman

机构信息

Institute of Sciences in Emergency Medicine, Department of Emergency Medicine, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.

Department of Emergency Medicine, Wayne State University School of Medicine, Detroit, MI 48201, USA.

出版信息

Biology (Basel). 2022 Oct 3;11(10):1455. doi: 10.3390/biology11101455.

Abstract

The mechanism of anaphylactic shock (AS) remains incompletely understood. The potassium channel blocker 4-aminopyridine (4-AP), the inhibitors of cystathionine γ-lyase (ICSE), dl-propargylglycine (DPG) or β-cyanoalanine (BCA), and the nitric oxide (NO) synthase produce vasoconstriction and could be an alternative for the treatment of AS. The aim of this study was to demonstrate the ability of L-NAME, ICSE alone or in combination with 4-AP to restore blood pressure (BP) and improve survival in ovalbumin (OVA) rats AS. Experimental groups included non-sensitized Wistar rats ( = 6); AS ( = 6); AS ( = 10 per group) treated i.v. with 4-AP (AS+4-AP), epinephrine (AS+EPI), AS+DPG, AS+BCA, or with L-NAME (AS+L-NAME); or AS treated with drug combinations 4-AP+DPG, 4-AP+BCA, 4-AP+L-NAME, or 4-AP+EPI. AS was induced by i.v. OVA (1 mg). Treatments were administered i.v. one minute after AS induction. Mean arterial BP (MAP), heart rate (HR), and survival were monitored for 60 min. Plasma levels of histamine, prostaglandin E2 (PGE2) and F2 (PGF2α), leukotriene B4 and C4, angiotensin II, vasopressin, oxidative stress markers, pH, HCO3, PaO2, PaCO2, and K+ were measured. OVA induced severe hypotension and all AS rats died. Moreover, 4-AP, 4-AP+EPI, or 4-AP+BCA normalized both MAP and HR and increased survival. All sensitized rats treated with 4-AP alone or with 4-AP+BCA survived. The time-integrated MAP "area under the curve" was significantly higher after combined 4-AP treatment with ICSE. Metabolic acidosis was not rescued and NO, ICSE, and Kv inhibitors differentially alter oxidative stress and plasma levels of anaphylactic mediators. The AS-induced reduction of serum angiotensin II levels was prevented by 4-AP treatment alone or in combination with other drugs. Further, 4-AP treatment combined with EPI or with BCA also increased serum PGF2α, whereas only the 4-AP+EPI combination increased serum LTB4. Serum vasopressin and angiotensin II levels were increased by 4-AP treatment alone or in combination with other drugs. Moreover, 4-AP alone and in combination with inhibition of cystathionine γ-lyase or EPI normalizes BP, increases serum vasoconstrictor levels, and improves survival in the Wistar rat model of AS. These findings suggest possible investigative treatment pathways for research into epinephrine-refractory anaphylactic shock in patients.

摘要

过敏性休克(AS)的机制仍未完全明确。钾通道阻滞剂4-氨基吡啶(4-AP)、胱硫醚γ-裂解酶(ICSE)抑制剂dl-炔丙基甘氨酸(DPG)或β-氰基丙氨酸(BCA)以及一氧化氮(NO)合酶可引起血管收缩,可能是治疗AS的替代方法。本研究旨在证明L-NAME、单独的ICSE或与4-AP联合使用恢复卵清蛋白(OVA)诱导的大鼠AS模型血压(BP)并提高生存率的能力。实验组包括未致敏的Wistar大鼠(n = 6);AS组(n = 6);AS组(每组n = 10)静脉注射4-AP(AS + 4-AP)、肾上腺素(AS + EPI)、AS + DPG、AS + BCA或L-NAME(AS + L-NAME);或AS组用药物组合4-AP + DPG、4-AP + BCA、4-AP + L-NAME或4-AP + EPI治疗。通过静脉注射OVA(1 mg)诱导AS。在AS诱导后1分钟静脉给药。监测平均动脉压(MAP)、心率(HR)和生存率60分钟。检测血浆组胺、前列腺素E2(PGE2)和F2(PGF2α)、白三烯B4和C4、血管紧张素II、血管加压素、氧化应激标志物、pH、HCO3、PaO2、PaCO2和K+水平。OVA诱导严重低血压,所有AS大鼠死亡。此外,4-AP、4-AP + EPI或4-AP + BCA使MAP和HR恢复正常并提高生存率。所有单独用4-AP或4-AP + BCA治疗的致敏大鼠均存活。4-AP与ICSE联合治疗后,时间积分MAP“曲线下面积”显著更高。代谢性酸中毒未得到纠正,NO、ICSE和Kv抑制剂对氧化应激和过敏介质血浆水平有不同影响。单独或与其他药物联合使用4-AP治疗可预防AS诱导的血清血管紧张素II水平降低。此外,4-AP与EPI或BCA联合治疗还可增加血清PGF2α,而只有4-AP + EPI组合可增加血清LTB4。单独或与其他药物联合使用4-AP治疗可增加血清血管加压素和血管紧张素II水平。此外,4-AP单独以及与胱硫醚γ-裂解酶抑制或EPI联合可使BP恢复正常,增加血清血管收缩剂水平,并提高Wistar大鼠AS模型的生存率。这些发现提示了对难治性过敏性休克患者进行研究的可能治疗途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a94/9598754/d589b3f1856b/biology-11-01455-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验